Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS).

@article{Li2012ImpactOL,
  title={Impact of long-term Xuezhikang therapy on cardiovascular events in high-risk patients with nonspecific, preexisting abnormal liver tests: a post-hoc analysis from Chinese Coronary Secondary Prevention Study (CCSPS).},
  author={Jian-jun Li and Zong-liang Lu and Wen-rong Kou and Roberto Bolli and Zuo Chen and Yang-feng Wu and Xue-hai Yu and Yu-cheng Zhao},
  journal={International journal of cardiology},
  year={2012},
  volume={154 3},
  pages={362-5}
}